AR
Anilkumar Ratilal Shah
About Anilkumar Ratilal Shah
Data last updated:
Anilkumar Ratilal Shah has 37 years in corporate governance. Holds Director role. Currently with 2 companies, including Iatros Pharmaceutical Pvt Ltd and Iatro Pharma And Biotech Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Iatros Pharmaceutical Pvt Ltd at ₹2.82 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Mar 1989 | 1989 | ₹2.82 Cr (FY 2025) | Active | |
| Director | 30 Mar 2010 | 2005 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anilkumar Ratilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anilkumar Ratilal Shah
Anilkumar Ratilal Shah has 37 years in corporate governance. Holds Director role. Currently with 2 companies, including Iatros Pharmaceutical Pvt Ltd and Iatro Pharma And Biotech Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Iatros Pharmaceutical Pvt Ltd at ₹2.82 Cr (FY 2025).
Anilkumar Ratilal Shah is associated with 2 companies as Director, including Iatros Pharmaceutical Pvt Ltd (₹2.82 Cr), Iatro Pharma And Biotech Limited.
Anilkumar Ratilal Shah has expertise in General Business, Technology.
Anilkumar Ratilal Shah has 37 years in corporate governance.
By reported revenue, the largest current company of Anilkumar Ratilal Shah is Iatros Pharmaceutical Pvt Ltd, with revenue of ₹2.82 Cr (FY 2025).
Anilkumar Ratilal Shah currently holds positions at 2 companies: Iatros Pharmaceutical Pvt Ltd (₹2.82 Cr), Iatro Pharma And Biotech Limited.